Publications
Found 7 results
Filters: Author is Y.Q. Yang [Clear All Filters]
“Construction and expression of prokaryotic expression vectors fused with genes of Magnaporthe oryzae effector proteins and mCherry”, vol. 14, pp. 10827-10836, 2015.
, “Construction of overexpression vectors of Magnaporthe oryzae genes BAS1 and BAS4 fusion to mCherry and screening of overexpression strains”, vol. 14, pp. 7068-7078, 2015.
, “Expression of Magnaporthe oryzae genes encoding cysteine-rich proteins secreted during nitrogen starvation and interaction with its host, Oryza sativa”, vol. 14, pp. 17099-17108, 2015.
, “Influence of cyclophilin D protein expression level on endothelial cell oxidative damage resistance”, vol. 14, pp. 4258-4268, 2015.
, “Upregulation of fibroblast growth factor 1 in the synovial membranes of patients with late stage osteoarthritis”, vol. 14, pp. 11191-11199, 2015.
, “Significant association of APOA5 and APOC3 gene polymorphisms with meat quality traits in Kele pigs”, vol. 12, pp. 3643-3650, 2013.
, “Novel NKX2-5 mutations responsible for congenital heart disease”, vol. 10, pp. 2905-2915, 2011.
, Akazawa H and Komuro I (2005). Cardiac transcription factor Csx/Nkx2-5: its role in cardiac development and diseases. Pharmacol. Ther. 107: 252-268.
http://dx.doi.org/10.1016/j.pharmthera.2005.03.005
Benson DW, Silberbach GM, Kavanaugh-McHugh A, Cottrill C, et al. (1999). Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J. Clin. Invest. 104: 1567-1573.
http://dx.doi.org/10.1172/JCI8154
PMid:10587520 PMCid:409866
Biben C, Weber R, Kesteven S, Stanley E, et al. (2000). Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ. Res. 87: 888-895.
PMid:11073884
Briggs LE, Takeda M, Cuadra AE, Wakimoto H, et al. (2008). Perinatal loss of Nkx2-5 results in rapid conduction and contraction defects. Circ. Res. 103: 580-590.
http://dx.doi.org/10.1161/CIRCRESAHA.108.171835
PMid:18689573 PMCid:2590500
Ching YH, Ghosh TK, Cross SJ, Packham EA, et al. (2005). Mutation in myosin heavy chain 6 causes atrial septal defect. Nat. Genet. 37: 423-428.
http://dx.doi.org/10.1038/ng1526
PMid:15735645
Elliott DA, Kirk EP, Yeoh T, Chandar S, et al. (2003). Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome. J. Am. Coll. Cardiol. 41: 2072-2076.
http://dx.doi.org/10.1016/S0735-1097(03)00420-0
Garg V, Kathiriya IS, Barnes R, Schluterman MK, et al. (2003). GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424: 443-447.
http://dx.doi.org/10.1038/nature01827
PMid:12845333
Garg V, Muth AN, Ransom JF, Schluterman MK, et al. (2005). Mutations in NOTCH1 cause aortic valve disease. Nature 437: 270-274.
http://dx.doi.org/10.1038/nature03940
PMid:16025100
Grow MW and Krieg PA (1998). Tinman function is essential for vertebrate heart development: elimination of cardiac differentiation by dominant inhibitory mutants of the tinman-related genes, XNkx2-3 and XNkx2-5. Dev. Biol. 204: 187-196.
http://dx.doi.org/10.1006/dbio.1998.9080
PMid:9851852
Hirayama-Yamada K, Kamisago M, Akimoto K, Aotsuka H, et al. (2005). Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am. J. Med. Genet. A 135: 47-52.
http://dx.doi.org/10.1002/ajmg.a.30684
PMid:15810002
Hosoda T, Komuro I, Shiojima I, Hiroi Y, et al. (1999). Familial atrial septal defect and atrioventricular conduction disturbance associated with a point mutation in the cardiac homeobox gene CSX/NKX2-5 in a Japanese patient. Jpn. Circ. J. 63: 425-426.
http://dx.doi.org/10.1253/jcj.63.425
PMid:10943630
Jenkins KJ, Correa A, Feinstein JA, Botto L, et al. (2007). Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115: 2995-3014.
http://dx.doi.org/10.1161/CIRCULATIONAHA.106.183216
PMid:17519397
Kasahara H and Benson DW (2004). Biochemical analyses of eight NKX2.5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies. Cardiovasc. Res. 64: 40-51.
http://dx.doi.org/10.1016/j.cardiores.2004.06.004
PMid:15364612
Kasahara H, Lee B, Schott JJ, Benson DW, et al. (2000). Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease. J. Clin. Invest. 106: 299-308.
http://dx.doi.org/10.1172/JCI9860
PMid:10903346 PMCid:314312
Kasahara H, Wakimoto H, Liu M, Maguire CT, et al. (2001). Progressive atrioventricular conduction defects and heart failure in mice expressing a mutant Csx/Nkx2.5 homeoprotein. J. Clin. Invest. 108: 189-201.
PMid:11457872 PMCid:203028
Kodo K, Nishizawa T, Furutani M, Arai S, et al. (2009). GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling. Proc Natl. Acad. Sci U. S. A. 106: 13933-13938.
http://dx.doi.org/10.1073/pnas.0904744106
PMid:19666519 PMCid:2728998
Li QY, Newbury-Ecob RA, Terrett JA, Wilson DI, et al. (1997). Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat. Genet. 15: 21-29.
http://dx.doi.org/10.1038/ng0197-21
PMid:8988164
Lloyd-Jones D, Adams R, Carnethon M, De Simone G, et al. (2009). Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: e21-181.
http://dx.doi.org/10.1161/CIRCULATIONAHA.108.191261
PMid:19075105
Lyons I, Parsons LM, Hartley L, Li R, et al. (1995). Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev. 9: 1654-1666.
http://dx.doi.org/10.1101/gad.9.13.1654
Matsson H, Eason J, Bookwalter CS, Klar J, et al. (2008). Alpha-cardiac actin mutations produce atrial septal defects. Hum. Mol. Genet. 17: 256-265.
http://dx.doi.org/10.1093/hmg/ddm302
PMid:17947298
Nora JJ and Nora AH (1976). Recurrence risks in children having one parent with a congenital heart disease. Circulation 53: 701-702.
PMid:1253394
Pashmforoush M, Lu JT, Chen H, Amand TS, et al. (2004). Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117: 373-386.
http://dx.doi.org/10.1016/S0092-8674(04)00405-2
Pierpont ME, Basson CT, Benson DW Jr, Gelb BD, et al. (2007). Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115: 3015-3038.
http://dx.doi.org/10.1161/CIRCULATIONAHA.106.183056
PMid:17519398
Prall OW, Menon MK, Solloway MJ, Watanabe Y, et al. (2007). An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 128: 947-959.
http://dx.doi.org/10.1016/j.cell.2007.01.042
PMid:17350578 PMCid:2092439
Razzaque MA, Nishizawa T, Komoike Y, Yagi H, et al. (2007). Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat. Genet. 39: 1013-1017.
http://dx.doi.org/10.1038/ng2078
PMid:17603482
Reamon-Buettner SM and Borlak J (2004). Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease. J. Med. Genet. 41: 684-690.
http://dx.doi.org/10.1136/jmg.2003.017483
PMid:15342699 PMCid:1735891
Roberts AE, Araki T, Swanson KD, Montgomery KT, et al. (2007). Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat. Genet. 39: 70-74.
http://dx.doi.org/10.1038/ng1926
PMid:17143285
Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, et al. (2006). Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science 311: 1287-1290.
http://dx.doi.org/10.1126/science.1124642
PMid:16439621
Sarkozy A, Conti E, Neri C, D’Agostino R, et al. (2005). Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J. Med. Genet. 42: e16.
http://dx.doi.org/10.1136/jmg.2004.026740
PMid:15689439 PMCid:1735979
Schott JJ, Benson DW, Basson CT, Pease W, et al. (1998). Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281: 108-111.
http://dx.doi.org/10.1126/science.281.5373.108
PMid:9651244
Shiojima I, Komuro I, Inazawa J, Nakahori Y, et al. (1995). Assignment of cardiac homeobox gene CSX to human chromosome 5q34. Genomics 27: 204-206.
http://dx.doi.org/10.1006/geno.1995.1027
PMid:7665173
Stallmeyer B, Fenge H, Nowak-Gottl U and Schulze-Bahr E (2010). Mutational spectrum in the cardiac transcription factor gene NKX2.5 (CSX) associated with congenital heart disease. Clin. Genet. 78: 533-540.
http://dx.doi.org/10.1111/j.1399-0004.2010.01422.x
PMid:20456451
Tanaka M, Chen Z, Bartunkova S, Yamasaki N, et al. (1999). The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 126: 1269-1280.
PMid:10021345